Seoul, Sept. 12 -- Global pharmaceutical leaders said on Thursday that cell therapy, artificial intelligence (AI)-driven drug development and diagnostics, digital healthcare, and aesthetic medicine are four frontiers that will lead South Korea's biotech industry, as per a report by Pulse, the English service of Maeil Business Newspaper Korea.

At the 2025 World Knowledge Forum K-Bio Night that took place on the same day at the Shilla Hotel in central Seoul, global pharma and biotech leaders took the stage to share growth strategies for K-bio's next leap.

As per the report, in his keynote, Cha Bio Group's head of the Global Research Institute Cha Kwang-ryul noted that cell therapy, a field that is rapidly gaining global attention, could b...